DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 776 filers reported holding DANAHER CORPORATION in Q2 2013. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,468,000 | +30.1% | 6,815 | +6.8% | 0.05% | +16.7% |
| Q2 2020 | $1,128,000 | +83.4% | 6,380 | +43.6% | 0.04% | +61.5% |
| Q1 2020 | $615,000 | -27.0% | 4,443 | -18.8% | 0.03% | -7.1% |
| Q4 2019 | $843,000 | +12.3% | 5,474 | +6.0% | 0.03% | +3.7% |
| Q3 2019 | $751,000 | -5.2% | 5,166 | -6.7% | 0.03% | 0.0% |
| Q2 2019 | $792,000 | -17.6% | 5,539 | -23.2% | 0.03% | -18.2% |
| Q1 2019 | $961,000 | +37.1% | 7,211 | +5.8% | 0.03% | +17.9% |
| Q4 2018 | $701,000 | +0.9% | 6,814 | +7.3% | 0.03% | +16.7% |
| Q3 2018 | $695,000 | +65.1% | 6,352 | +46.6% | 0.02% | +50.0% |
| Q2 2018 | $421,000 | -42.3% | 4,334 | -42.6% | 0.02% | -42.9% |
| Q1 2018 | $730,000 | +1.1% | 7,548 | -2.7% | 0.03% | -3.4% |
| Q4 2017 | $722,000 | +44.4% | 7,755 | +33.3% | 0.03% | +31.8% |
| Q3 2017 | $500,000 | +9.2% | 5,816 | +7.3% | 0.02% | +10.0% |
| Q2 2017 | $458,000 | -4.8% | 5,420 | -3.6% | 0.02% | -20.0% |
| Q1 2017 | $481,000 | +12.6% | 5,623 | +2.5% | 0.02% | +13.6% |
| Q4 2016 | $427,000 | +10.1% | 5,485 | +10.7% | 0.02% | +4.8% |
| Q3 2016 | $388,000 | -4.4% | 4,953 | +24.1% | 0.02% | -8.7% |
| Q2 2016 | $406,000 | +4.1% | 3,991 | -4.3% | 0.02% | +4.5% |
| Q1 2016 | $390,000 | +1.0% | 4,170 | -0.6% | 0.02% | +10.0% |
| Q4 2015 | $386,000 | +8.7% | 4,194 | +1.9% | 0.02% | 0.0% |
| Q3 2015 | $355,000 | -14.0% | 4,116 | -13.5% | 0.02% | +5.3% |
| Q2 2015 | $413,000 | +6.2% | 4,760 | +4.2% | 0.02% | -26.9% |
| Q1 2015 | $389,000 | -47.9% | 4,569 | -47.4% | 0.03% | -51.9% |
| Q4 2014 | $746,000 | +170.3% | 8,689 | +145.9% | 0.05% | +145.5% |
| Q3 2014 | $276,000 | -74.7% | 3,533 | -74.4% | 0.02% | -72.5% |
| Q2 2014 | $1,091,000 | +204.7% | 13,794 | +193.4% | 0.08% | +196.3% |
| Q1 2014 | $358,000 | +1.7% | 4,701 | +3.3% | 0.03% | -3.6% |
| Q4 2013 | $352,000 | -53.3% | 4,553 | -58.1% | 0.03% | -36.4% |
| Q3 2013 | $754,000 | +1.9% | 10,879 | -6.4% | 0.04% | -25.4% |
| Q2 2013 | $740,000 | – | 11,621 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |